Executive Summary

In a recent interview, ProQR’s founder Daniel de Boer cited the enormous impact that fellow Dutch businessman Henri Termer played in getting his fledging biotech start-up off the ground – especially given the circumstances.  Some 10 years ago, the then twenty-something budding biotech entrepreneur crossed the Atlantic on a chance that Termeer would answer what amounted to an unscheduled desk-knock at the rare disease pioneer’s office at Genzyme HQ in Cambridge, MA.  He did – and the rest is history.